Recurrent
19
6
7
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (19)
DPX-Survivac and Checkpoint Inhibitor in DLBCL
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in Women
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion
NK Cell Therapy Recurrent/Refractory Elderly AML
The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse
Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients